Breo Ellipta is a prescription medication used to treat chronic obstructive pulmonary disease (COPD) and asthma. It is a combination of two active ingredients, fluticasone furoate and vilanterol, which work together to help improve lung function and reduce inflammation in the airways.
Fluticasone furoate is a corticosteroid that helps to reduce inflammation in the lungs, while vilanterol is a long-acting beta agonist that helps to relax the muscles in the airways, making it easier to breathe. When used together in Breo Ellipta, these two medications provide powerful relief for those suffering from COPD or asthma.
Breo Ellipta comes in the form of a dry powder inhaler, making it easy to use and convenient for patients to take their medication on a daily basis. It is important to follow the dosing instructions provided by your healthcare provider to ensure you are getting the maximum benefit from this medication.
As with any medication, there are potential side effects to be aware of when taking Breo Ellipta. These may include headache, sore throat, and upper respiratory tract infection. It is important to discuss any concerns or side effects with your healthcare provider.
Overall, Breo Ellipta is a valuable treatment option for those with COPD or asthma, providing effective relief and improved lung function. If you have been prescribed Breo Ellipta, be sure to use it as directed and consult with your healthcare provider if you have any questions or concerns.
EN 
ES 
FR 
PT 
ZH